September 29, 2026
NHIA’s Infusion Practice Standard for Anaphylaxis Kit Medication Selection offers guidance on selecting medications and supplies for anaphylaxis kits used by patients receiving infusion therapy at home. Adapt the guidance to each patient and organization using clinical judgment, prescriber orders, and applicable requirements.
NHIA is requesting that public stakeholders review and provide feedback on the draft practice standard. Your comments on proposed practice standards play a key role in the standards development process. You can comment on all text published within the practice standard section of the following document:
The comment period closes October 30, 2026.
The target audience includes clinicians, regulatory agencies, reimbursement professionals, and industry stakeholders.
Please submit all comments to standards@nhia.org.